✦ LIBER ✦

A time course analysis of glycaemic improvements with albiglutide, a long-acting GLP-1-receptor agonist for the treatment of type 2 diabetes

✍ Scribed by Reusch, J.; Rosenstock, J.; Bush, M.; Yang, M.; Stewart, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The long-acting GLP-1-receptor agonist a

✍ J. Rosenstock, F. Yang; M. Bush, J. Reusch; Stewart, M 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 441 KB

Safety, tolerability, pharmacokinetics a

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB

A comparison of currently available GLP-

✍ Montanya, Eduard 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 414 KB

Pharmacological profile of lixisenatide:

✍ Ulrich Werner; Guido Haschke; Andreas W. Herling; Werner Kramer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 734 KB

Effects of liraglutide (NN2211), a long-

✍ M. N. Feinglos; M. F. Saad; F. X. Pi-Sunyer; B. An; O. Santiago; on behalf of th 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

The safety and tolerability of GLP-1 rec

✍ Vanita R. Aroda; Robert Ratner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB